Further characterization of cross-reactive anti-human leukocyte mAbs by use of equine leukocyte cell lines EqT8888 and eCAS

Veterinary Immunology and Immunopathology

Volumn 119, Issue 1-2, 2007, Pages 100-105

  Steinbach, Falko ^a,c   Saunders, Kelly ^b   Kydd, Julia H ^b   Ibrahim, Sherif ^a  

^a LEIBNIZ INSTITUTE FOR ZOO AND WILDLIFE RESEARCH   (Germany)

^b ANIMAL HEALTH TRUST   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

eCAS; EqT8888; Equine; Horse; Immunology; Leukocyte differentiation

Indexed keywords

LEUKOCYTE ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; BONE MARROW CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; CROSS REACTION; FLOW CYTOMETRY; HORSE; IMMUNOREACTIVITY; LYMPHOID CELL LINE; LYMPHOMA CELL LINE; NONHUMAN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL LINE; CROSS REACTIONS; HORSES; HUMANS; LEUKOCYTES;

EQUIDAE;

EID: 34548048556     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.06.027     Document Type: Article

References (11)

1. Bosshart H., and Jarrett R.F. Deficient major histocompatibility complex class II antigen presentation in a subset of Hodgkin's disease tumor cells. Blood 92 (1998) 2252-2259
2. Drillenburg P., and Pals S.T. Cell adhesion receptors in lymphoma dissemination. Blood 95 (2000) 1900-1910
3. Flaminio J., Ibrahim S., Lunn D.P., Stark R., and Steinbach F. Further analysis of anti-human leukocyte mAbs with reactivity to equine leukocytes by two-colour flow cytometry and immunohistochemistry. Vet. Immunol. Immunopathol. 119 (2007) 92-99
4. Hieronymus T., Gust T.C., Kirsch R.D., Jorgas T., Blendinger G., Goncharenko M., Supplitt K., Rose-John S., Muller A.M., and Zenke M. Progressive and controlled development of mouse dendritic cells from Flt3+ CD11b+ progenitors in vitro. J. Immunol. 174 (2005) 2552-2562
5. Hormanski C.E., Ruax R., Pourciau S.S., Folsom R.W., and Horohov D.W. Induction of lymphokine-activated killer cells of equine origin: specificity for equine target cells. Vet. Immunol. Immunopathol. 32 (1992) 25-36
6. Ibrahim S., and Steinbach F. Non-HLDA8 animal homologue section anti-leukocyte mAbs tested for cross-reactivity with equine leukocytes. Vet. Immunol. Immunopathol. 119 (2007) 81-91
7. Ibrahim S., Saunders K., Kydd J.H., Lunn D.P., and Steinbach F. Screening of anti-human leukocyte mabs for cross reactivity with equine leukocytes. Vet. Immunol. Immunopathol. 119 (2007) 63-80
8. Nakamura S., Nagahama M., Kagami Y., Yatabe Y., Takeuchi T., Kojima M., Motoori T., Suzuki R., Taji H., Ogura M., Mizoguchi Y., Okamoto M., Suzuki H., Oyama A., Seto M., Morishima Y., Koshikawa T., Takahashi T., Kurita S., and Suchi T. Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases. Am. J. Surg. Pathol. 23 (1999) 363-376
9. Steinbach F., and Thiele B. Phenotypic investigation of mononuclear phagocytes by flow cytometry. J. Immunol. Methods 174 (1994) 109-122
10. Werners A.H., Bull S., Fink-Gremmels J., and Bryant C.E. Generation and characterisation of an equine macrophage cell line (e-CAS cells) derived from equine bone marrow cells. Vet. Immunol. Immunopathol. 97 (2004) 65-76
11. Ziegler-Heitbrock H.W., Thiel E., Futterer A., Herzog V., Wirtz A., and Riethmüller G. Establishment of a human cell line (MonoMac 6) with characteristics of mature monocytes. Int. J. Cancer 41 (1988) 456-461